NASDAQ: ICCTIcoreconnect Inc Stock
$0.19+0.02 (+11.76%)
Updated Dec 9, 2024
ICCT Price
$0.19
Fair Value Price
N/A
Market Cap
$4.50M
52 Week Low
$0.15
52 Week High
$3.20
P/E
-0.06x
P/B
-1.49x
P/S
0.35x
PEG
N/A
Dividend Yield
N/A
Revenue
$11.05M
Earnings
-$29.07M
Gross Margin
77.5%
Operating Margin
-253.09%
Profit Margin
-278.6%
Debt to Equity
-5.71
Operating Cash Flow
-$8M
Beta
2.86
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ICCT's potential to beat the market
- ICCT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
ICCT
RankedUnranked of 52
RankedUnranked of 52
Be the first to know about important ICCT news, forecast changes, insider trades & much more!
ICCT News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ICCT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ICCT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ICCT is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ICCT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ICCT due diligence checks available for Premium users.
Valuation
ICCT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.06x
Industry
24.56x
Market
29.44x
ICCT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.49x
Industry
3.86x
ICCT's financial health
Profit margin
Revenue
$2.8M
Net Income
-$6.0M
Profit Margin
-238.9%
ICCT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ICCT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.2M
Liabilities
$17.2M
Debt to equity
-5.71
ICCT's short-term liabilities ($13.12M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ICCT's long-term liabilities ($4.12M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ICCT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ICCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$250.5k
Investing
-$565.2k
Financing
$780.8k
ICCT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ICCT vs Health Information Service Stocks
Icoreconnect Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.